MolecuLight Successfully Completes

(Adnkronos) – The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security  TORONTO, Dec. 12, 2023 /PRNewswire/ — MolecuLight Inc., the leader in point-of-care fluorescence imaging that